Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial, page-191

That's a good point u make l reckon

If our understanding of lMU is correct ....then they will effectively control a whole new and disruptive IP platform .

If that is so ....then it wont b a case of speed dating (as Paul Hopper describes )....and an outright buy out at 500 mill ....plus or what ever .

There are many possible outcomes l suspect ....involving multiple licensing deals .....JV's etc etc. Maybe with multiple parties ......who knows ?

Sure as a shareholder a 5 - 10 times return on investment is really nice .......but IMU has the potential to return 100 fold .

Read Few Pennies summations of potential income streams and valuations etc etc .


it's likely none of us on this thread are really qualified to do an absolute or informed critical analysis of the technology or the opportunity.

However the spin so far looks pretty exciting ..... and although it may be years in the actual rollout ......

I think the wait will be worth it .

Cheers

VA